ESR2 and Parkinson disease: There is evidence that the genetic factors influencing inflammation could affect the risk of PD: San Luciano et al. investigated the polymorphisms for the promoter of the IL-6 gene and the beta estrogen receptor (ESR2), and showed that the GG genotype increased the risk of PD and had a different distribution between the sexes.